Title
Category
Credits
Event date
Cost
  • Bipolar Disorder
  • Bipolar Depression
  • Depression
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Dr Goldberg describes the role of the clinician as that of a travel agent, asking the patient, “Where do you want to go; what do you want it to be like there; how do you want to get there;” etc, then providing the patient with the related evidence-supported information. Learn how to become your patients’ travel agent for their journey through optimizing treatment strategies for type I and type II bipolar disorder.
  • Bipolar Disorder
  • Bipolar Depression
  • Depression
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
As novel agents join the treatment landscape for bipolar I and bipolar II disorder and new data emerge on existing therapeutics, clinicians need education on the latest evidence of the safety and efficacy profiles of existing and emerging treatments for bipolar I and bipolar II disorder. Join Drs Goldberg, DelBello, and Swartz in examining how to integrate this information into clinical practice and provide efficacious and tolerable treatment for patients with bipolar I and bipolar II disorder.
  • Bipolar Disorder
  • Bipolar Depression
  • Depression
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Involving patients in designing their own treatment strategies according to their tolerability criteria can help combat the 90% nonadherence rate in patients being treated for bipolar disorder. Find out from experts about best practices in addressing patient concerns and balancing tolerability with efficacy and adherence in treating patients with bipolar disorder.
  • Delivery of Care
  • Muscular Dystrophy
  • Neurology
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
A detailed, modern digest of key advances in the diagnosis, treatment, and management of patients with Duchenne muscular dystrophy.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • Education
  • Functional Impairment
  • Geriatric Psychiatry
  • Neuroimaging
  • Neurology
  • Patient/Physician Communication
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Drs Anderson and Malone cover the types of dementia and their indicators, ways to approach care for mild cognitive impairment (MCI) and mild dementia, and treatment options available or in the pipeline for disease intervention. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • Education
  • Functional Impairment
  • Geriatric Psychiatry
  • Neuroimaging
  • Neurology
  • Patient/Physician Communication
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Drs Anderson and Malone discuss the burden of, signs and symptoms of, diagnostic tools and criteria for mild cognitive impairment (MCI) and mild/early dementia and the benefits of early diagnosis. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers.
  • Bipolar Disorder
  • Bipolar Depression
  • Depression
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Adopting consensus guidelines while applying new evidence on the latest treatment options can often be a matter of balancing risks, benefits, and tolerability when addressing acute episodes in bipolar I disorder. Sit in on the discussion between three experts as they discuss guideline-directed treatment strategies that address manic and mixed episodes in patients with bipolar I disorder, and listen to one patient’s journey to hope and recovery.
  • Mood Disorders
  • Women’s Mental Health
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Program IntroductionMood disorders throughout women's reproductive stages require comprehensive care to alleviate unnecessary suffering, comorbidities, and unwanted outcomes.Learning ObjectivesAfter completing this educational activity, you should be able to:
  • Alzheimer Disease
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation
$0.00
New biomarker technology and advancements in treatment options can lead to earlier diagnosis of AD and initiation of appropriate disease modifying therapies.

Pages